Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma

References

• Chow WH, Devesa SS, Warren JL. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628–31
   PubMed Web of Science ®Google Scholar
• Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics. CA-A Cancer J Clin 2004; 54: 8–29
   PubMed Web of Science ®Google Scholar
• Vogelzang NJ, Stadler WM. Kidney Cancer. Lancet 1998; 352: 1691–6
   PubMed Web of Science ®Google Scholar
• Saitoh H. Distant metastasis of renal adenocacinoma. Cancer 1981; 48: 1487–91
   PubMed Web of Science ®Google Scholar
• Swanson DA, Orovan WL, Johnson DE, Giacco G. Osseous metastases secondary to renal cell carcinoma. Urology 1981; 18: 556–61
   PubMedGoogle Scholar
• Vogelzang NJ. Treatment options in metastatic renal carcinoma: An embarrassment of riches. J Clin Oncol 2006; 24: 1–3
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC, White DE, Steinberg SM. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2. Ann Surg 1998; 228: 307–19
   PubMed Web of Science ®Google Scholar
• Almgard LE, Fernstrom I, Haverling M, Ljungqvist A. Treatment of renal adenocarcinoma by embolic occlusion of the renal circulation. Br J Urol 1973; 45: 474–9
   PubMedGoogle Scholar
• Christensen K, Dyreborg U, Andersen JF, Nissem HM. The value of transvascular embolization in the treatment of renal carcinoma. J Urol 1985; 133: 191–3
   PubMed Web of Science ®Google Scholar
• Barton PP, Waneck RE, Karnel FJ, Ritschl P, Kramer J, Lechner GL. Embolization of bone metastases. JVIR 1996; 7: 81–8
   Google Scholar
• Sun S, Lang EV. Bone metastases from renal cell carcinoma: Preoperative embolization. JVIR 1998; 9: 263–9
   Google Scholar
• Bowers TA, Murray JA, Charnsangavej C, Soo CS, Chuang VP, Wallace S. Bone metastases from renal carcinoma: The preoperative use of transcatheter arterial occlusion. J Bone Joint Surg 1982; 64: 749–54
   PubMedGoogle Scholar
• Chatziioannou AN, Johnson ME, Pneumaticos SG, Lawrence DD, Carrasco CH. Preoperative embolization of bone metastases from renal cell carcinoma. Euro Radiol 2000; 10: 593–6
   PubMed Web of Science ®Google Scholar
• Drooz AT, Lewis CA, Allen TE, Citron SJ, Cole PE, Freeman NJ, et al. Quality improvement guidelines for percutaneous transcatheter embolization. J Vasc Interv Radiol 2003; 14: S237–S242
   Google Scholar
• Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol 2003; 21: 3127–32
   PubMed Web of Science ®Google Scholar
• Chuang VP, Wallace S, Swanson D, Zoroza J, Handel SF, Schwarten DA, Murray J. Arterial occlusion in the management of pain from metastatic renal carcinoma. Radiology 1979; 133: 611–4
   PubMedGoogle Scholar
• Wallace S, Granmayeh M, DeSantos LA, Murray JA, Romsdahl MM, Bracken RB, et al. Arterial occlusion of pelvic bone tumors. Cancer 1979; 43: 322–8
   PubMed Web of Science ®Google Scholar
• Weber J. Palliative embolization in bone metastasis of hypernephroma using oily contrast-labeled gel. Ann Radiol 1982; 25: 460–2
   PubMedGoogle Scholar
• Varma J, Huben RP, Wajsman Z, Pontes JE. Therapeutic embolization of pelvic metastases of renal cell carcinoma. J Urol 1984; 131: 647–9
   PubMedGoogle Scholar
• Eustatia-Rutten CF, Romijn JA, Guijt MJ, Vielvoye GJ, van den Berg R, Corssmit EPM, et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrin Metab 2003; 88: 3184–9
   PubMedGoogle Scholar
• Uemura A, Fujimoto H, Yasuda S, Osaka I, Goto N, Shinozaki M, et al. Transcatheter arterial embolization for bone metastases from hepatocellular carcinoma. Euro Radiol 2001; 11: 1457–62
   PubMedGoogle Scholar
• Berenstein A, Kricheff II. Catheter and material selection for transarterial embolization: Technical considerations. Radiology 1979; 132: 619–30
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Sindel T, Luleci E. Repeated palliative embolization of renal cell carcinoma metastases. Clin Radiol 2002; 57: 319–20
   PubMedGoogle Scholar
• Lipton A, Colombo-Berra A, Bukowski RM, Rosen L, Zheng M, Urbanowitz G. Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid. Clin Can Res 2004; 10(Suppl): s6397–s6403
   Google Scholar
• Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach III M, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005; 97: 798–804
   PubMedGoogle Scholar
• Onufrey V, Mohiuddin M. Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 1985; 11: 2007–9
   PubMedGoogle Scholar
• Lee J, Hodgson D, Chow E, Bezjak A, Catton P, Tsuji D, et al. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 2005; 104: 1894–900
   PubMedGoogle Scholar
• Svedman C, Sandstrom P, Pisa P, Blomgren H, Lax I, Kalkner K-M, et al. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006; 45: 870–5
   PubMed Web of Science ®Google Scholar